The aspirin mortality benefit remained highly significant in propensity score-matched analysis (matched HR 0.12, 95%CI 0.06–0.25).
← all excerpts
Paradoxical myocardial infarction risk with dual antiplatelet therapy in East Asian ischaemic stroke: a nationwide real-world cohort study and pharmacogenomic risk prediction model.
1
—
—